通过结合异常皮质厚度和心室形态测量来改善异常性正常压力水脑症的诊断
Yifeng Yang1, Meijing Yan1, Xiao Liu1
1Department of Radiology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Frontiers in aging neuroscience
|March 15, 2024
概括
通过结合心室和皮质成像,可以改善异常正常压力水脑 (iNPH) 诊断. 皮层厚度,特别是在带状皮层,是iNPH检测的关键生物标志物.
科学领域:
- 神经成像是一种神经成像.
- 神经学 神经学
- 医学诊断 医学诊断 医学诊断
背景情况:
- 异常性正常压力水脑 (iNPH) 诊断传统上依赖于心室大小,忽视大脑围膜变化.
- 目前用于iNPH的成像标记器缺乏对皮质结构变化的关注.
研究的目的:
- 调查结合心室形态测量和皮质结构测量对iNPH的诊断有效性.
- 开发和评估用于使用集成成像功能检测iNPH的机器学习模型.
主要方法:
- 招募了57名iNPH患者和55名健康对照 (HC).
- 从MRI扫描中进行心室形态的手动测量 (例如,埃文斯指数) 和基于表面的皮质厚度分析.
- 开发并验证了三种机器学习模型 (心室形态,皮质厚度和融合) 使用十倍交叉验证和独立测试集.
主要成果:
- iNPH患者表现出明显的皮质厚度差异,包括额叶,叶和带膜皮层的缩小.
- 融合模型 (心室+皮质数据) 获得了90.43%的准确性,优于单一特征模型.
- 右半径带状皮层的皮层厚度是区分iNPH和HC的最重要的预测因素.
结论:
- 皮层结构变化在iNPH诊断中起着重要作用.
- 结合心室和皮质成像,为改善临床医生对iNPH的识别和检测提供了新的见解.
更多相关视频
15:263D Modeling of the Lateral Ventricles and Histological Characterization of Periventricular Tissue in Humans and Mouse
Published on: May 19, 2015
14.1K
14:59Neuronavigation and Laparoscopy Guided Ventriculoperitoneal Shunt Insertion for the Treatment of Hydrocephalus
Published on: October 14, 2022
7.2K
相关概念视频
01:28Special considerations while measuring blood pressure
When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...